Comprehensive analysis of the expression and prognostic value of ARMCs in pancreatic adenocarcinoma

Abstract Background Pancreatic adenocarcinoma (PAAD) has a very poor prognosis, and there are few treatments for PAAD. Therefore, it is important to find some biomarkers for the diagnosis and treatment of PAAD. Although some members of Armadillo repeat containing proteins (ARMCs) have been implicate...

Full description

Saved in:
Bibliographic Details
Main Authors: Guanxiang Zhuo, Shengzhai Lin, Fei Yuan, Qiaoling Zheng, Yinpin Guo, Zuwei Wang, Jianfei Hu, Meihong Yao, Fuxiu Zhong, Shi Chen, Yanling Chen, Huixing Chen
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-024-13365-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544550285312000
author Guanxiang Zhuo
Shengzhai Lin
Fei Yuan
Qiaoling Zheng
Yinpin Guo
Zuwei Wang
Jianfei Hu
Meihong Yao
Fuxiu Zhong
Shi Chen
Yanling Chen
Huixing Chen
author_facet Guanxiang Zhuo
Shengzhai Lin
Fei Yuan
Qiaoling Zheng
Yinpin Guo
Zuwei Wang
Jianfei Hu
Meihong Yao
Fuxiu Zhong
Shi Chen
Yanling Chen
Huixing Chen
author_sort Guanxiang Zhuo
collection DOAJ
description Abstract Background Pancreatic adenocarcinoma (PAAD) has a very poor prognosis, and there are few treatments for PAAD. Therefore, it is important to find some biomarkers for the diagnosis and treatment of PAAD. Although some members of Armadillo repeat containing proteins (ARMCs) have been implicated in the development of certain cancers, their relationship with PAAD remains unknown. In this study, we aimed to explore the expression and prognostic value of ARMCs in PAAD. Methods We used the The Cancer Genome Atlas (TCGA) database for survival analysis. Then, Gene Expression Profiling Interactive Analysis (GEPIA), the cBioPortal database, the Human Protein Atlas (HPA), Kaplan-Meier Plotter, LinkedOmics Database, Gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG), Cytoscape and Timer were used to analyze the relationship between ARMCs and PAAD. In addition, we established a prognostic model of ARMCs for PAAD. Immunohistochemistry (IHC) was also performed. Then Image-J was used to analyze all images obtained from the experiment, and GraphPad-Prism (9.5.1) was used for statistical analysis to verify the expression of ARMCs in PAAD. Results In the TCGA database, the expressions of ARMC1, 2, 3, 5, 6, 7, 8, 9 and 10 in PAAD tissues were significantly higher than those in normal tissues. And higher expressions of ARMC1 and 10 were associated with lower survival rate of PAAD patients. In addition, ARMC2, 5, 6, and 10 were positively associated with advanced stages of PAAD. ARMCs mutations occur in 11% of PAAD patients, and missense mutations and amplification of ARMCs account for most of them. In addition, ARMC5 and ARMC10 were independent prognostic factors in univariate and multivariate Cox regression analyses. Finally, through our confirmation experiment, it was found that the expression of ARMC1 and 10 in PAAD tissues was significantly increased compared with those in paracancer tissue. Conclusion This study suggests that ARMCs may be able to play important roles in PAAD, and they can act as biomarkers, providing valuable clues for the treatment and diagnosis of PAAD.
format Article
id doaj-art-daefa1cea6064ff0b85ebbf5938dcb25
institution Kabale University
issn 1471-2407
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj-art-daefa1cea6064ff0b85ebbf5938dcb252025-01-12T12:27:14ZengBMCBMC Cancer1471-24072025-01-0125111810.1186/s12885-024-13365-5Comprehensive analysis of the expression and prognostic value of ARMCs in pancreatic adenocarcinomaGuanxiang Zhuo0Shengzhai Lin1Fei Yuan2Qiaoling Zheng3Yinpin Guo4Zuwei Wang5Jianfei Hu6Meihong Yao7Fuxiu Zhong8Shi Chen9Yanling Chen10Huixing Chen11Department of Hepatobiliary Surgery, Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union HospitalDepartment of Hepatobiliary Surgery, Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union HospitalDepartment of Hepatobiliary Surgery, Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union HospitalDepartment of Pathology, Fujian Medical University Union HospitalDepartment of Hepatobiliary Surgery, Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union HospitalShengli Clinical Medical College of Fujian Medical University, Fujian Medical UniversityShengli Clinical Medical College of Fujian Medical University, Fujian Medical UniversityDepartment of Pathology, Fujian Medical University Union HospitalDepartment of Hepatobiliary Surgery Nursing, Fujian Medical University Union HospitalShengli Clinical Medical College of Fujian Medical University, Fujian Medical UniversityDepartment of Hepatobiliary Surgery, Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union HospitalDepartment of Hepatobiliary Surgery, Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Union HospitalAbstract Background Pancreatic adenocarcinoma (PAAD) has a very poor prognosis, and there are few treatments for PAAD. Therefore, it is important to find some biomarkers for the diagnosis and treatment of PAAD. Although some members of Armadillo repeat containing proteins (ARMCs) have been implicated in the development of certain cancers, their relationship with PAAD remains unknown. In this study, we aimed to explore the expression and prognostic value of ARMCs in PAAD. Methods We used the The Cancer Genome Atlas (TCGA) database for survival analysis. Then, Gene Expression Profiling Interactive Analysis (GEPIA), the cBioPortal database, the Human Protein Atlas (HPA), Kaplan-Meier Plotter, LinkedOmics Database, Gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG), Cytoscape and Timer were used to analyze the relationship between ARMCs and PAAD. In addition, we established a prognostic model of ARMCs for PAAD. Immunohistochemistry (IHC) was also performed. Then Image-J was used to analyze all images obtained from the experiment, and GraphPad-Prism (9.5.1) was used for statistical analysis to verify the expression of ARMCs in PAAD. Results In the TCGA database, the expressions of ARMC1, 2, 3, 5, 6, 7, 8, 9 and 10 in PAAD tissues were significantly higher than those in normal tissues. And higher expressions of ARMC1 and 10 were associated with lower survival rate of PAAD patients. In addition, ARMC2, 5, 6, and 10 were positively associated with advanced stages of PAAD. ARMCs mutations occur in 11% of PAAD patients, and missense mutations and amplification of ARMCs account for most of them. In addition, ARMC5 and ARMC10 were independent prognostic factors in univariate and multivariate Cox regression analyses. Finally, through our confirmation experiment, it was found that the expression of ARMC1 and 10 in PAAD tissues was significantly increased compared with those in paracancer tissue. Conclusion This study suggests that ARMCs may be able to play important roles in PAAD, and they can act as biomarkers, providing valuable clues for the treatment and diagnosis of PAAD.https://doi.org/10.1186/s12885-024-13365-5Pancreatic adenocarcinomaTumor markerARMCsImmune infiltrationPrognostic mode
spellingShingle Guanxiang Zhuo
Shengzhai Lin
Fei Yuan
Qiaoling Zheng
Yinpin Guo
Zuwei Wang
Jianfei Hu
Meihong Yao
Fuxiu Zhong
Shi Chen
Yanling Chen
Huixing Chen
Comprehensive analysis of the expression and prognostic value of ARMCs in pancreatic adenocarcinoma
BMC Cancer
Pancreatic adenocarcinoma
Tumor marker
ARMCs
Immune infiltration
Prognostic mode
title Comprehensive analysis of the expression and prognostic value of ARMCs in pancreatic adenocarcinoma
title_full Comprehensive analysis of the expression and prognostic value of ARMCs in pancreatic adenocarcinoma
title_fullStr Comprehensive analysis of the expression and prognostic value of ARMCs in pancreatic adenocarcinoma
title_full_unstemmed Comprehensive analysis of the expression and prognostic value of ARMCs in pancreatic adenocarcinoma
title_short Comprehensive analysis of the expression and prognostic value of ARMCs in pancreatic adenocarcinoma
title_sort comprehensive analysis of the expression and prognostic value of armcs in pancreatic adenocarcinoma
topic Pancreatic adenocarcinoma
Tumor marker
ARMCs
Immune infiltration
Prognostic mode
url https://doi.org/10.1186/s12885-024-13365-5
work_keys_str_mv AT guanxiangzhuo comprehensiveanalysisoftheexpressionandprognosticvalueofarmcsinpancreaticadenocarcinoma
AT shengzhailin comprehensiveanalysisoftheexpressionandprognosticvalueofarmcsinpancreaticadenocarcinoma
AT feiyuan comprehensiveanalysisoftheexpressionandprognosticvalueofarmcsinpancreaticadenocarcinoma
AT qiaolingzheng comprehensiveanalysisoftheexpressionandprognosticvalueofarmcsinpancreaticadenocarcinoma
AT yinpinguo comprehensiveanalysisoftheexpressionandprognosticvalueofarmcsinpancreaticadenocarcinoma
AT zuweiwang comprehensiveanalysisoftheexpressionandprognosticvalueofarmcsinpancreaticadenocarcinoma
AT jianfeihu comprehensiveanalysisoftheexpressionandprognosticvalueofarmcsinpancreaticadenocarcinoma
AT meihongyao comprehensiveanalysisoftheexpressionandprognosticvalueofarmcsinpancreaticadenocarcinoma
AT fuxiuzhong comprehensiveanalysisoftheexpressionandprognosticvalueofarmcsinpancreaticadenocarcinoma
AT shichen comprehensiveanalysisoftheexpressionandprognosticvalueofarmcsinpancreaticadenocarcinoma
AT yanlingchen comprehensiveanalysisoftheexpressionandprognosticvalueofarmcsinpancreaticadenocarcinoma
AT huixingchen comprehensiveanalysisoftheexpressionandprognosticvalueofarmcsinpancreaticadenocarcinoma